Parameters of inflammation and infection in a community based case-control study of coronary heart disease


      Background: increased levels of systemic inflammatory markers appear to be related to coronary heart disease (CHD) both in asymptomatic individuals and in subjects with established CHD. Whether these associations are related to confounding coronary risk factors or are explicable through chronic infectious conditions is not clear. Objectives: (1) to determine whether subjects with stable CHD differ from normal controls in inflammatory markers (CRP, SAA and fibrinogen) and/or in serostatus of four infectious agents (Helicobacter pylori, Chlamydia pneumoniae, CMV and EBV), independent of classical coronary risk factors. (2) To determine whether these inflammatory markers are related to the serostatus against these four infectious agents either in patients with CHD or in normal subjects. Methods: in a large epidemiologic survey, 446 out of 16 307 men at work, aged 35–59 years, had antecedents of myocardial infarction, CABG or PTCA or had prominent Q/QS waves on their resting ECG. They were compared with double the number (n=892) of men, matched for age, educational level and industry. Inflammatory biomarkers (CRP, fibrinogen and SAA) and antibodies against H. pylori, C. pneumoniae, CMV and EBV were measured, besides classical coronary risk factors. Results: in univariate analyses, cases had higher CRP, fibrinogen and SAA levels than controls, but no differences were observed in serumantibody levels to any of the infectious agents. Markers of previous infections were not related to inflammatory biomarkers. In multivariate analyses CRP was significantly different between cases and controls independent of differences in other coronary risk factors and in the use of lipid lowering drugs and antiplatelet aggregants. Conclusion: in men at work with CHD, CRP levels are significantly different from controls, independent of known risk factors. No association was found between inflammatory biomarkers and positive serostatus against four infectious agents, neither in the patients nor in the healthy controls.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Morrow D.A.
        • Rifai N.
        • Antman E.M.
        C-reactive protein in a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI IIa substudy.
        J. Am. Coll. Cardiol. 1998; 31: 1460-1465
        • Pietilä K.O.
        • Harmoinen A.P.
        • Jokiniitty J.
        • Pasternack A.I.
        Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment.
        Eur. Heart J. 1996; 17: 1345-1349
        • Liuzzo G.
        • Biasucci L.M.
        • Gallimore J.R.
        The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina.
        New Engl. J. Med. 1994; 331: 417-424
        • Wilhelmsen L.
        • Svärdsudd K.
        • Korsan-Bengtsen K.
        • Larsson B.
        • Welin L.
        • Tibblin G.
        Fibrinogen as a risk factor for stroke and myocardial infarction.
        New Engl. J. Med. 1984; 311: 501-505
        • Kannel W.B.
        • Wolf P.A.
        • Castelli W.P.
        • D'Agostino R.B.
        • The Framingham Study
        Fibrinogen and risk of cardiovascular disease.
        J. Am. Med. Assoc. 1987; 258: 1183-1186
        • Yarnell J.W.
        • Baker I.A.
        • Sweetnam P.M.
        • Bainton D.
        • O'Brien J.R.
        • Whitehead P.J.
        • et al.
        • The Caerphilly and Speedwell Collaborative Heart Disease Studies
        Fibrinogen, viscosity and white blood cell count are major risk factors for ischemic heart disease.
        Circulation. 1991; 83: 836-844
        • Thompson S.G.
        • Kienast J.
        • Pyke S.D.
        • Haverkate F.
        • van de Loo J.C.
        • European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group
        Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris.
        New Engl. J. Med. 1995; 332: 635-641
        • Heinrich J.
        • Balleisen L.
        • Schulte H.
        • Assman G.
        • van de Loo J.
        Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men.
        Arterioscler. Thromb. 1994; 14: 54-59
        • Kuller L.H.
        • Tracy R.P.
        • Shaten J.
        • Meilahn E.N.
        • Multiple Risk Factor Intervention Trial
        Relationship of C-reactive protein and coronary heart disease in the MRFIT nested case-control study.
        Am. J. Epidemiol. 1996; 144: 537-547
        • Ridker P.M.
        • Cushman M.
        • Stampfer M.
        • Tracy R.
        • Hennekens C.H.
        Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men.
        New Engl. J. Med. 1997; 336: 939-973
        • Tracy R.P.
        • Lemaitre R.N.
        • Psaty B.M.
        • Ives D.G.
        • Evans R.W.
        • Cushman M.
        • et al.
        Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.
        Arterioscler. Thromb. Vasc. Biol. 1997; 17: 1121-1127
        • Ridker P.M.
        • Hennekens C.H.
        • Buring J.E.
        • Rifai N.
        C-reactive protein and other markers of inflammation in the prediction of cardiovascular diseases in women.
        New Engl. J. Med. 2000; 342: 836-843
        • Koenig W.
        • Sund M.
        • Fröhlich M.
        C-reactive protein, a sensitive marker of systematic inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Results from the MONICA-Augsburg cohort study 1984–1992.
        Circulation. 1999; 99: 237-242
        • Haverkate F.
        • Thompson S.G.
        • Pyke S.D.
        • Gallimore J.R.
        • Pepys M.B.
        • European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group
        Production of C-reactive protein and risk of coronary events in stable and unstable angina.
        Lancet. 1997; 349: 412-426
        • Visser M.
        • Bouter L.M.
        • McQuillan G.M.
        • Wener M.H.
        • Harris T.B.
        Elevated C-reactive protein levels in overweight and obese adults.
        J. Am. Med. Assoc. 1999; 282: 2131-2135
        • Cook D.G.
        • Mendall M.A.
        • Whincup P.H.
        • et al.
        C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors.
        Atherosclerosis. 2000; 149: 139-150
        • Ross R.
        Atherosclerosis—an inflammatory disease.
        New Engl. J. Med. 1999; 340: 115-126
        • Bruggeman C.A.
        • Marjorie H.J.
        • Nelissen-Vrancken G.
        Cytomegalovirus and atherogenesis.
        Antiviral. Res. 1999; 43: 135-144
        • Zhu J.
        • Quyyumi A.A.
        • Norman J.E.
        • Csako G.
        • Epstein S.E.
        Cytomegalovirus in the pathogenesis of atherosclerosis.
        J. Am. Coll. Cardiol. 1999; 34: 1738-1743
        • Adler S.P.
        • Hur J.K.
        • Wang J.B.
        • Vetrovec G.W.
        Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis.
        J. Infect. Dis. 1998; 177: 209-212
        • Melnick J.L.
        • Adam E.
        • Debakey M.E.
        Cytomegalovirus and atherosclerosis.
        Eur. Heart J. 1994; 14: 30-38
        • McDonagh T.A.
        • Woodward M.
        • Morrison C.E.
        • et al.
        Helicobacter pylori infection and coronary heart disease in the North-Glasgow MONICA population.
        Eur. Heart J. 1997; 18: 1257
        • Miettinen H.
        • Lehto S.
        • Saikku P.
        Association of Chlamidia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland.
        Eur. Heart J. 1996; 17: 682-688
        • Mendell M.A.
        • Goggin P.M.
        • Molineaux N.
        Relation of Helicobacter pylori infection and coronary heart disease.
        Br. Heart J. 1994; 71: 437-439
        • Giles W.H.
        • Croft J.B.
        • Ford E.S.
        • Greenlund K.J.
        Lack of association between Helicobacter pylori and Herpex simplex 1 seropositivity and the likelihood for myocardial infarction or stroke.
        CVD Prevention. 1999; 2: 199-204
        • Anderson J.L.
        • Carlquist J.
        • Muhlestein J.B.
        • Horne B.D.
        • Elmer S.P.
        Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factor for coronary artery disease and myocardial infarction.
        J. Am. Coll. Cardiol. 1998; 32: 35-41
        • Koenig W.
        • Rothenbacher D.
        • Hoffmeister A.
        • et al.
        Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease.
        Circulation. 1999; 100: 2326-2331
        • Whincap P.H.
        • Mendell M.A.
        • Perry I.J.
        • Strachan D.P.
        • Walker M.
        Prospective relations between Helicobacter pylori infection, coronary heart disease and stroke in middle-aged men.
        Heart. 1996; 75: 568-572
        • Strandberg T.E.
        • Tilvis R.S.
        • Vuoristo M.
        • Lindroos M.
        • Kosunen T.U.
        Prospective study of Helicobacter pylori seroposivity and cardiovascular diseases in a general elderly population.
        Br. Med. J. 1997; 314: 317-318
        • Wald N.J.
        • Law M.R.
        • Morris J.K.
        • Bagnall A.M.
        Helicobacter pylori infection and mortality from ischaemic heart disease: negative results from a large, prospective study.
        Br. Med. J. 1997; 315: 1199-1201
      1. Folsom AR, Nieto JR, Sorlic P, Chambless LE, Graham DY for the Atherosclerosis Risk in Communities (ARIC) Study investigators. Helicobacter pylori seropositivity and coronary heart disease incidence. Circulation 1998;98:845–50.

        • Coetsier P.
        • De Backer G.
        • De Corte W.
        • et al.
        Etude Belge de stress au travail: aperçu de modèles de recherche et des outils d'investigation.
        Psychologie et Psychométrie. 1996; 17: 17-35
        • Rose G.
        • Blackburn H.
        • Gillum R.F.
        • Prineas R.J.
        Cardiovascular Survey Methods. second ed. WHO, Geneva1988
        • The EUROGAST Study Group
        An international association between Helicobacter pylori infection and gastric cancer.
        Lancet. 1993; 341: 1359-1362
      2. WHO MONICA project. MONICA Manual, Geneva, WHO, 1990.

        • De Backer G.
        Nutrition and health: an interuniversity study. Regional differences in dietary habits, coronary risk factors and mortality rates in Belgium. I. Design and methodology.
        Acta Cardiologica. 1984; 39: 285-292
        • Ledue T.B.
        • Weiner D.L.
        • Sipe J.D.
        • Poulin S.E.
        • Collins M.F.
        • Rifai N.
        Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum.
        Ann. Clin. Biochem. 1998; 35: 745-753
        • Rifai N.
        • Tracy R.P.
        • Ridker P.M.
        Clinical efficacy of an automated high-sensitivity C-reactive protein assay.
        Clin. Chem. 1999; 45: 2136-2141
      3. N Latex SAA. Instruction leaflet. Dade Behring Marburg GmbH, 1998.

        • Poole S.
        • Walker D.
        • Gaines Das R.E.
        • Gallimore J.R.
        • Pepys M.B.
        The first international standard for serum amyloid A protein (SAA). Evaluation in an international collaborative study.
        J. Immunol. Methods. 1998; 214: 1-10
        • Dati F.
        • Schumann G.
        • Thomas L.
        • et al.
        Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardisation against the IFCC/BCR/CAP reference material (CRM 470).
        Eur. J. Clin. Chem. Clin. Biochem. 1996; 34: 517-520
        • Rossi E
        • Mondonico P
        • Lombardi A
        • Preda L
        Method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulometers.
        Thromb Res. 1988; 52: 453-468
        • Alain C.
        • Poon L.
        • Chan C.
        Enzymatic determination of total cholesterol.
        Clin. Chem. 1974; 20: 470-475
        • Lopez-Virella M.
        • Stone P.
        • Ellis S.
        • Colwell J.
        Cholesterol determination in high density lipoproteins separated by three different methods.
        Clin. Chem. 1977; 23: 882-884
        • Troch T.T.
        • Van Renterghem L.
        A new ELISA for Chlamydia Pneumoniae IgG antibodies.
        Clin. Chem. Lab. Med. (suppl). 1999; 37: 588
        • Friedman G.D.
        • Klatsky A.L.
        • Siegelaub A.B.
        The leukocyte count as a predictor of myocardial infarction.
        New Engl. J. Med. 1974; 290: 1275-1278
        • Danesh J.
        • Peto R.
        Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies.
        Br. Med. J. 1998; 316: 1130-1132
        • Danesh J.
        • Whincup P.
        • Walker M.
        • et al.
        Low grade inflammation and coronary heart disease: prospective study and updated meta-analysis.
        Br. Med. J. 2000; 321: 199-204
        • Danesh J.
        • Whincup P.
        • Walker M.
        • et al.
        Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis.
        Br. Med. J. 2000; 321: 208-212
        • Glynn J.R.
        Helicobacter pylori and the heart.
        Lancet. 1994; 344: 146
        • De Backer G.
        Helicobacter pylori infection and coronary heart disease.
        Eur. Heart J. 1997; 18: 1206
        • Ridker P.M.
        • Rifari N.
        • Pfeffer M.A.
        • Sacks F.
        • Braunwald E.
        Long-term effects of pravastatin on plasma concentration of C-reactive protein.
        Circulation. 1999; 100: 230-235